Back

Speaker "Gurkern Sufi" Details Back

 

Topic

Data Analytics and machine learning

Abstract

Ravata Solutions has developed an embryo health diagnostics to improve the pregnancy rates for patients going through in-vitro fertilization. Our platform is finding it's initial traction in the mouse IVF industry which amounts to a TAM greater than $850M. Our human application would be classified as a class 2 medical device and open up a market with a TAM greater than $4.75B. We are currently looking for an investment lead knowledgeable in the medical device space for our seed round this coming January and to begin clinical trials with IVF partners come summer 2020.
Who is this presentation for?

Prerequisite knowledge:

What you'll learn?

Profile

I began my work in the field of biotech after receiving grant funding to functionalize antibodies to graphene field effect transistors to detect the presence of antigens in solution. This led me down the field of bio-electronics where my current work has brought me to the characterization of embryo impedances to evaluate reproductive competency. Ravata Solutions was founded to bridge the work done in the semi-conductor industry to the needs of the biotech community. We developed a platform of bio-chips that are cell specific and are positioning ourselves to develop a bio-chip with medical device classification for the IVF industry.